New Fund
Paris, France-based Kurma Partners closed €215M to back startups developing disruptive therapeutics for severe or incurable diseases and to create new biotech companies.
London, United Kingdom-based Evertrue Capital closed an oversubscribed...
Spain-based Seaya secured a €600m first close toward a €1bn target to...
Sweden-based Creandum closed €668M Fund VIII to back early-stage...
London-based AP Ventures closed $300M Fund III to invest in early-stage...
Stockholm, Sweden-based BackingMinds secured a €50M first close to back...
Barcelona-based Masia closed its first fund at €18M to back early-stage...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
